GenSciP107
/ GeneScience
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2025
GenSciP107, a MICA/B-directed and Fc-enhanced antibody, potently inhibits tumor growth via ADCC and stimulation of immune response
(AACR 2025)
- "These data highlight the potential of GenSciP107 as a novel cancer therapy with multiple mechanisms of action and support its further evaluation in IND-enabling studies."
IO biomarker • Genito-urinary Cancer • Hepatocellular Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor • Urothelial Cancer • CD8 • MICA • MICB • NKG2D
1 to 1
Of
1
Go to page
1